Clinical trial Recruiting at 1 site Observational Ages 21 and up

Evaluation of a care program for adults with childhood-onset disabilities

Official title: Evaluating a Model of Transitional and Lifelong Care for Adults With Childhood-Onset Disabilities

Run by Western University, Canada · NCT05849285 · Data updated 2026-11-12

This study is testing a new care program for adults who had disabilities from childhood to see if it helps them get better healthcare and improve their overall health.

More Cerebral Palsy trials

Quick facts

Study typeObservational
Ages21 Years and up
SexAll
Enrollment410 (estimated)
SponsorWestern University, Canada
Academic / other
Locations1 site (London, Ontario)
StatusRecruiting
StartedJanuary 3, 2024
Main results expectedDecember 31, 2026
Study endsDecember 2027
Registry record updatedFebruary 27, 2026
Trial IDNCT05849285 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 21 years old with a childhood-onset disability and their primary caregivers.

Probably not a fit

Patients experiencing deterioration due to a progressive health condition may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the Transitional and Lifelong Care (TLC) program designed for youth and adults with childhood-onset disabilities, primarily focusing on those with cerebral palsy, spina bifida, and developmental disabilities. The TLC program aims to address health inequities faced by this population during their transition from pediatric to adult healthcare services by providing coordinated management of their mental, social, and physical health needs. The study will assess the effectiveness of the TLC model in reducing barriers to care and improving health outcomes for these individuals.

Why it matters

Potential benefit: If successful, this program could significantly improve the quality of life and health outcomes for adults with childhood-onset disabilities.

How similar studies have gone: While this approach is innovative in its focus on transitional care for this specific population, similar models have shown promise in improving health outcomes in other settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Each participant dyad will consist of one person, of either sex and gender, who is over the age of 21 years with a childhood-onset disability, and the primary caregiver (based on contact hours) or support person, of either sex and gender, involved in their care. In cases where the patient participant is independent with care, a spouse or family member may still participate in the caregiver portion of the study.

2\. Patient participants will have continuously resided in Ontario during the years of 2015 to 2020 to facilitate full data retrieval from the administrative dataset.

3\. Healthcare providers, of any discipline, who provide care to adults with childhood-onset conditions in the TLC program.

Exclusion Criteria:

Patient participants will be ineligible if they are in a phase of deterioration associated with a progressive health condition identified either personally or by the caregiver participant.

Where it's running

  • Parkwood Institute
    London, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Laura K Brunton, PhD — Western University
  • Study coordinator: Laura K Brunton, PhD
  • Email: lbrunto3@uwo.ca
  • Phone: 15196612111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.